hVIVO — Pivotal Phase III human challenge trial contract signed with ILiAD Biotechnologies

Tender opportunity published by hVIVO plc on TenderSignal, the UK public sector tender monitoring platform.

Contracting Authority

hVIVO plc

Region

United Kingdom

Contract Type

services

Source

RNS-FEED

hVIVO plc signed a contract with ILiAD Biotechnologies Inc to conduct the world first pivotal Phase III human challenge trial for B. pertussis (whooping cough) vaccine candidate BPZE1. hVIVOs largest HCT to date with over 500 participants anticipated. Multi-year contract with revenue recognition fro

Sign up free to receive matched tender alerts like this one

Browse more UK public sector tenders · View pricing